Julie Burek is VP, Finance of Voyager Therapeutics, Inc.. Currently has a direct ownership of 52,458 shares of VYGR, which is worth approximately $301,633. The most recent transaction as insider was on Mar 21, 2022, when has been sold 2,649 shares (Common Stock) at a price of $8.49 per share, resulting in proceeds of $22,490. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.5K
0% 3M change
0% 12M change
Total Value Held $301,633

Julie Burek Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2022
SELL
Open market or private sale
$22,490 $8.49 p/Share
2,649 Reduced 4.81%
52,458 Common Stock
Feb 17 2022
SELL
Open market or private sale
$2,801 $3.55 p/Share
789 Reduced 1.41%
55,107 Common Stock
Feb 11 2022
SELL
Open market or private sale
$1,213 $3.36 p/Share
361 Reduced 0.64%
55,896 Common Stock
Jan 13 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 15.09%
56,257 Common Stock
Jan 12 2022
SELL
Open market or private sale
$811 $3.06 p/Share
265 Reduced 0.57%
46,257 Common Stock
Jan 03 2022
SELL
Open market or private sale
$8,668 $2.83 p/Share
3,063 Reduced 6.18%
46,522 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$7,045 $2.3 p/Share
3,063 Added 5.82%
49,585 Common Stock
Nov 26 2021
BUY
Grant, award, or other acquisition
-
13,500 Added 22.49%
46,522 Common Stock
JB

Julie Burek

VP, Finance
Cambridge, MA

Track Institutional and Insider Activities on VYGR

Follow Voyager Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

News

Receive news related to Voyager Therapeutics, Inc.

Track Activities on VYGR